257. Hepatic glycogenosis Clinical trials / Disease details

Clinical trials : 14 /  Drugs : 27 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 8

  
3 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04930627
(ClinicalTrials.gov)		July 202111/6/2021Safety and Efficacy of Empagliflozin in GSD1b Patients With NeutropeniaEvaluation of Efficacy and Safety of Empagliflozin in Treatment of Neutropenia in Patients With Glycogenosis IbGlucose 6 Phosphatase DeficiencyDrug: EmpagliflozinChildren's Memorial Health Institute, PolandDepartment of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of WarsawNot yet recruitingN/AN/AAll20Phase 2Poland
2NCT03218904
(ClinicalTrials.gov)		March 17, 201713/7/2017Glycogen Storage Disease Breath Test StudyApplication of Novel Techniques to Devise Nutritional Therapies in Subjects With Glycogen Storage Disease Type IPatient Compliance;HealthyDietary Supplement: Glucose intake;Dietary Supplement: Carbohydrates intakeUniversity of British ColumbiaSaudi Arabian Cultural Bureau, Ottawa;Canadian Institutes of Health Research (CIHR)Recruiting5 Years35 YearsAll38N/ACanada
3NCT02176096
(ClinicalTrials.gov)		July 201424/6/2014Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration TrialComparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration TrialGlycogen Storage Disorder Type 1;Hypoglycemia;Cornstarch;GlycosadeDietary Supplement: GlycosadeUniversity of ManitobaCo-Investigator - Dr. Cheryl Rockman-GreenbergCompleted5 Years18 YearsAll4N/ACanada